Filing Details

Accession Number:
0001651844-19-000019
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-07-02 11:33:12
Reporting Period:
2019-07-01
Accepted Time:
2019-07-02 11:33:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1018735 Nymox Pharmaceutical Corp NYMX In Vitro & In Vivo Diagnostic Substances (2835) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1651844 George James Robinson 10 East Lee Street
Suite 2705
Baltimore MD 21202
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-07-01 2,200 $1.37 3,472,750 No 4 P Direct
Common Stock Acquisiton 2019-07-01 4,806 $1.37 3,477,556 No 4 P Direct
Common Stock Acquisiton 2019-07-01 800 $1.36 3,478,356 No 4 P Direct
Common Stock Acquisiton 2019-07-01 295 $1.37 3,478,651 No 4 P Direct
Common Stock Acquisiton 2019-07-01 28 $1.37 3,478,679 No 4 P Direct
Common Stock Acquisiton 2019-07-01 100 $1.37 3,478,779 No 4 P Direct
Common Stock Acquisiton 2019-07-01 371 $1.36 3,479,150 No 4 P Direct
Common Stock Acquisiton 2019-07-01 400 $1.36 3,479,550 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct